SHORT PRODUCT INFORMATION: NAME OF THE MEDICINAL PRODUCT: ZINCOVITE FORT 30 mg/5 ml syrup. ACTIVE INGREDIENT: Each 5 ml (1 scoop) syrup contains 30 mg of Zinc (as zinc sulfate heptahydrate). PHARMACOLOGICAL PROPERTIES: Pharmacotherapeutic group: Other mineral supplements ATC Code: A12CB01. THERAPEUTIC INDICATIONS: It is used in the prevention or treatment of zinc deficiency. POZOLOGY / FREQUENCY AND DURATION OF APPLICATION: Unless recommended otherwise by the doctor; Used once a day at the indicated scale. CONTRAINDICATIONS: Contraindicated in people allergic to zinc salts or other components of the syrup. SPECIAL USE WARNINGS AND PRECAUTIONS: It can be used with meals, but its use with foods rich in calcium, phosphorus or phytate should be avoided. In patients who develop severe nausea, vomiting or acute indigestion, the use of the drug should be stopped and a doctor should be consulted. Taking it for a long time or in high doses can cause copper deficiency. Patients with rare hereditary problems of fructose intolerance, glycogalactose malabsorption or sucrase-isomaltase insufficiency should not use this medicine. ZINCOVIT FORT contains 50 mg of propylene glycol in a dose of 5 ml. No effects are expected against propylene glycol. Since ZINCOVIT FORT contains methyl parahydroxybenzoate (E218), it may cause allergic reactions (possibly delayed). INTERACTIONS WITH OTHER MEDICINAL PRODUCTS AND OTHER MODES OF INTERACTION: Co-administration of zinc salts with tetracyclines and penicillamines may cause a decrease in effect. These substances should be used with zinc salts every three hours. High doses of iron preparations inhibit the absorption of zinc, and zinc intake may reduce iron absorption. PREGNANCY CATEGORY: C. LACTATION PERIOD: ZINCOVIT FORT passes into breast milk; Therefore, it should be used under the supervision of a doctor during breastfeeding. UNDESIRED EFFECTS: Blood and lymphatic system disorders: Uncommon: Neutropenia, leukopenia-anemia Immune system disorders: Very rare: Allergic reactions Nervous system disorders: Uncommon: Dizziness, headache, nervousness, drowsiness Vascular disorders: Very rare: Hypotension, arrhythmia, electrocardiographic changes in potassium deficiency Gastrointestinal system disorders Common: Vomiting Uncommon: Nausea, abdominal pain, indigestion, gastric irritation, gastritis, dyspepsia, diarrhea General disorders and administration site conditions: Not known: Irritability, lethargy and headache. Long-term use can lead to copper deficiency. QUALITY AND CONTENT OF THE PACKAGING: Each box contains a 100 ml amber bottle with a plastic cap and a 5 ml bottle.
There is a pipette. REPORTING SUSPICIOUS ADVERSE REACTIONS: Reporting suspected adverse reactions of drugs after authorization is of great importance. Reporting,
It allows continuous monitoring of the benefit/risk balance of the drug. Healthcare professionals should report any suspected adverse reaction to the Turkish Pharmacovigilance Center (TÜFAM).
(www.titck.gov.tr, e-mail: [email protected]; tel: 0 800 314 00 08; fax: 0 312 218 35 99). LICENSE OWNER İstanbul İlaç San. and Tic. Inc. Kartal/Istanbul LICENSE NUMBER
2019/510 9. FIRST LICENSE DATE/LICENSE RENOVATION DATE 10.10.2019 SALES AND MARKETING: FARMAVİP İLAÇ VE KOZMETIK SANAYİ VE TİCARET A.Ş. Arabayatagi Mah. 2. Celik Sok. No:13/2
Yıldırım/BURSA Tel: 0 224 341 10 55 e-mail: [email protected]

For more information, contact our company.